Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Chem ; 132: 106387, 2023 03.
Article in English | MEDLINE | ID: mdl-36724660

ABSTRACT

Aberrant activation of the Hedgehog (Hh) signaling pathway has been observed in various human malignancies. Glioma-associated oncogene transcription factor 1 (GLI1) is the ultimate effector of the canonical Hh pathway and has also been identified as a common regulator of several tumorigenic pathways prevalent in Hh-independent cancers. The anti-cancer potential of GLI1 antagonism with small molecule inhibitors has demonstrated initial promise; however, the continued development of GLI1 inhibitors is still needed. We previously identified a scaffold containing an 8-hydroxyquinoline as a promising lead GLI1 inhibitor (compound 1). To further develop this scaffold, we performed a systematic structure-activity relationship study to map the structural requirements of GLI1 inhibition by this chemotype. A series of biophysical and cellular experiments identified compound 39 as an enhanced GLI1 inhibitor with improved activity. In addition, our studies on this scaffold suggest a potential role for SRC family kinases in regulating oncogenic GLI1 transcriptional activity.


Subject(s)
Neoplasms , Transcription Factors , Humans , Transcription Factors/metabolism , Zinc Finger Protein GLI1/metabolism , Hedgehog Proteins/metabolism , Signal Transduction , Cell Proliferation , Cell Line, Tumor
2.
ChemMedChem ; 18(10): e202200541, 2023 05 16.
Article in English | MEDLINE | ID: mdl-36792530

ABSTRACT

The Enterovirus (EV) genus includes several important human and animal pathogens. EV-A71, EV-D68, poliovirus (PV), and coxsackievirus (CV) outbreaks have affected millions worldwide, causing a range of upper respiratory, skin, and neuromuscular diseases, including acute flaccid myelitis, and hand-foot-and-mouth disease. There are no FDA-approved antiviral therapeutics for these enteroviruses. This study describes novel antiviral compounds targeting the conserved non-structural viral protein 2C with low micromolar to nanomolar IC50 values. The selection of resistant mutants resulted in amino acid substitutions in the viral capsid protein, implying these compounds may play a role in inhibiting the interaction of 2C and the capsid protein. The assembly and encapsidation stages of the viral life cycle still need to be fully understood, and the inhibitors reported here could be useful probes in understanding these processes.


Subject(s)
Enterovirus Infections , Enterovirus , Neuromuscular Diseases , Animals , Humans , Antiviral Agents/pharmacology , Antiviral Agents/metabolism , Capsid Proteins/metabolism , Enterovirus Infections/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...